Organization
UCSD School of Medicine, La Jolla
2 abstracts
Abstract
ANIFROLUMAB, AN ANTI-INTERFERON-ALPHA RECEPTOR MONOCLONAL ANTIBODY, IN MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) Org: Northwell Health, Great Neck, NY, United States of America, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States of America, Philadelphia VA Medical Center and University of Pennsylvania, Philadelphia, United States, Graham Hughes Lupus Research Laboratory Division of Women's Health, London, United Kingdom, UCSD School of Medicine, La Jolla,
Abstract
BILAG-MEASURED IMPROVEMENT IN MODERATELY AND SEVERELY AFFECTED BODY SYSTEMS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) BY EPRATUZUMAB: RESULTS FROM EMBLEM™, A PHASE IIB STUDY Org: UCSD School of Medicine, La Jolla, Cedars-Sinai Medical Center and UCLA School of Medicine, Los Angeles, The Johns Hopkins University, Baltimore, United States, Université catholique de Louvain, Brussels, Belgium, Massachusetts General Hospital, Boston, MA, USA,